Phoshphodiesterase-5 inhibitors: Novel weapons against Alzheimer's disease

International Journal of Neuroscience

Volumn 120, Issue 12, 2010, Pages 746-751

  Sabayan, Behnam ^a   Zamiri, Nima ^b   Farshchizarabi, Sara ^c   Sabayan, Behrang ^d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF TORONTO   (Canada)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alzheimer's disease; Neurogenesis; Sildenafil

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; CYCLIC GMP; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; PHOSPHODIESTERASE V;

ALZHEIMER DISEASE; DRUG ACTIVITY; DRUG MECHANISM; GENE OVEREXPRESSION; HIPPOCAMPUS; HUMAN; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; REVIEW; UPREGULATION; DISEASE COURSE; DRUG EFFECT; ENZYMOLOGY; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ALZHEIMER DISEASE; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; HUMANS; NEURONS; PHOSPHODIESTERASE 5 INHIBITORS;

EID: 78149249616     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2010.520381     Document Type: Review

References (56)

1. Alvarez-Buylla, A., & Lim, D. A. (2004). For the long run: Maintaining germinal niches in the adult brain. Neuron, 41, 683-686.
2. Aversa, A., Vitale, C., Volterrani, M., Fabbri, A., Spera, G., Fini, M., et al. (2008). Chronic administration of sildenafil improves markers of endothelial function in men with type 2 diabetes. Diabetic Medicine, 25, 37-44.
3. Balcells, M., Wallins, J. S., & Edelman, E. R. (2008). Amyloid beta toxicity dependent upon endothelial cell state. Neuroscience Letters, 441, 319-322.
4. Becker, M., Lavie, V., & Solomon, B. (2007). Stimulation of endogenous neurogenesis by anti-efrh immunization in a trans-genic mouse model of alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America, 104, 1691-1696.
5. Bender, A. T., & Beavo, J. A. (2004). Specific localized expression of cgmp pdes in purkinje neurons and macrophages. Neurochemistry International, 45, 853-857.
6. Blennow, K., De Leon, M. J., & Zetterberg, H. (2006). Alzheimer's disease. Lancet, 368, 387-403.
7. Boger, R. H., Bode-Boger, S. M., Thiele, W., Junker, W., Alexander, K., & Frolich, J. C. (1997). Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation, 95, 2068-2074.
8. Cardillo, C., Campia, U., Kilcoyne, C. M., Bryant, M. B., & Panza, J. A. (2002). Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation, 105, 452-456.
9. Caretti, A., Bianciardi, P., Ronchi, R., Fantacci, M., Guazzi, M., & Samaja, M. (2008). Phosphodiesterase-5 inhibition abolishes neuron apoptosis induced by chronic hypoxia independently of hypoxia-inducible factor-1alpha signaling. Experimental Biology and Medicine (Maywood), 233, 1222-1230.
10. Chen, Q., Nakajima, A., Choi, S. H., Xiong, X., Sisodia, S. S., & Tang, Y. P. (2008). Adult neurogenesis is functionally associated with ad-like neurodegeneration. Neurobiology of Disease, 29, 316-326.
11. Chen, J., Tu, Y., Moon, C., Matarazzo, V., Palmer, A. M., & Ronnett, G. V. (2004). The localization of neuronal nitric oxide synthase may influence its role in neuronal precursor proliferation and synaptic maintenance. Developmental Biology, 269, 165-182.
12. Cholerton, B., Gleason, C. E., Baker, L. D., & Asthana, S. (2002). Estrogen and alzheimer's disease: The story so far. Drugs & Aging, 19, 405-427.
13. Ciani, E., Guidi, S., Bartesaghi, R., & Contestabile, A. (2002). Nitric oxide regulates cgmp-dependent camp-responsive element binding protein phosphorylation and bcl-2 expression in cerebellar neurons: Implication for a survival role of nitric oxide. Journal of Neurochemistry, 82, 1282-1289.
14. Corretti, M. C., Anderson, T. J., Benjamin, E. J., Celermajer, D., Charbonneau, F., Creager, M. A., et al. (2002). Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the international brachial artery reactivity task force. Journal of the American College of Cardiology, 39, 257-265.
15. Counts, S. E., He, B., Che, S., Ikonomovic, M. D., Dekosky, S. T., Ginsberg, S. D., et al. (2007). Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in alzheimer disease. Archives of Neurology, 64, 1771-1776.
16. Cummings, J. L., Vinters, H. V., Cole, G. M., & Khachaturian, Z. S. (1998). Alzheimer's disease: Etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology, 51, s2-17; discussion s65-7.
17. Das, A., Xi, L., & Kukreja, R. C. (2005). Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis. Essential role of nitric oxide signaling. Journal of Biological Chemistry, 280, 12944-12955.
18. Dede, D. S., Yavuz, B., Yavuz, B. B., Cankurtaran, M., Halil, M., Ulger, Z., et al. (2007). Assessment of endothelial function in alzheimer's disease: Is alzheimer's disease a vascular disease? Journal of the American Geriatrics Society, 55, 1613-1617.
19. De la torre, J. C. (2002). Vascular basis of alzheimer's pathogenesis. Annals of the New York Academy of Sciences, 977, 196-215.
20. De Vente, J. (2004). cGMP: A second messenger for acetylcholine in the brain? Neurochemistry International, 45, 799-812.
21. Elder, G. A., De Gasperi, R., & Gama Sosa, M. A. (2006). Research update: Neurogenesis in adult brain and neuropsychiatric disorders. Mount Sinai Journal of Medicine, 73, 931-940.
22. Fiscus, R. R. (2002). Involvement of cyclic gmp and protein kinase G in the regulation of apoptosis and survival in neural cells. Neurosignals, 11, 175-190.
23. Ghofrani, H. A., Osterloh, I. H., & Grimminger, F. (2006). Sildenafil: From angina to erectile dysfunction to pulmonary hypertension and beyond. Nature Reviews. Drug Discovery, 5, 689-702.
24. Ghofrani, H. A., Voswinckel, R., Reichenberger, F., Olschewski, H., Haredza, P., Karadas, B., et al. (2004). Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: A randomized prospective study. Journal of the American College of Cardiology, 44, 1488-1496.
25. Hansson, O., Zetterberg, H., Vanmechelen, E., Vanderstichele, H., Andreasson, U., Londos, E., et al. (2010). Evaluation of plasma abeta(40) and abeta(42) as predictors of conversion to alzheimer's disease in patients with mild cognitive impairment. Neurobiology of Aging, 31, 357-367.
26. Hardy, J., & Selkoe, D. J. (2002). The amyloid hypothesis of alzheimer's disease: Progress and problems on the road to therapeutics. Science, 297, 353-356.
27. Haughey, N. J., Liu, D., Nath, A., Borchard, A. C., & Mattson, M. P. (2002). Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: Implications for the patho-genesis of alzheimer's disease. Neuromolecular Medicine, 1, 125-135.
28. Hindley, S., Juurlink, B. H., Gysbers, J. W., Middlemiss, P. J., Herman, M. A., & Rathbone, M. P. (1997). Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cgmp-dependent mechanism. Journal of Neuroscience Research, 47, 427-439.
29. Iadecola, C. (2005). Rescuing troubled vessels in alzheimer's disease. Nature Medicine, 11, 923-924.
30. Jackson, G., Gillies, H., & Osterloh, I. (2005). Past, present, and future: A 7-year update of viagra (sildenafil citrate). International Journal of Clinical Practice, 59, 680-691.
31. Kempermann, G., & Gage, F. H. (2002). Genetic determinants of adult hippocampal neurogenesis correlate with acquisition, but not probe trial performance, in the water maze task. European Journal of Neuroscience, 16, 129-136.
32. Khalil, Z., Logiudice, D., Khodr, B., Maruff, P., & Masters, C. (2007). Impaired peripheral endothelial microvascular responsiveness in alzheimer's disease. Journal of Alzheimer's Disease, 11, 25-32.
33. Ko, I. G., Shin, M. S., Kim, B. K., Kim, S. E., Sung, Y. H., Kim, T. S., et al. (2009). Tadalafil improves short-term memory by suppressing ischemia-induced apoptosis of hippocampal neuronal cells in gerbils. Pharmacology, Biochemistry, and Behavior, 91, 629-635.
34. Kraus, M. M., & Prast, H. (2001). The nitric oxide system modulates the in vivo release of acetylcholine in the nucleus accum-bens induced by stimulation of the hippocampal fornix/fimbria-projection. European Journal of Neuroscience, 14, 1105-1112.
35. Krause, M., & Pedarzani, P. (2000). A protein phosphatase is involved in the cholinergic suppression of the ca(2+)-activated k(+) current si(ahp) in hippocampal pyramidal neurons. Neuropharma-cology, 39, 1274-1283.
36. Masterman, D. (2003). Treatment of the neuropsychiatric symptoms in alzheimer's disease. Journal of the American Medical Directors Association, 4, s146-s54.
37. Mattson, M. P. (2008). Glutamate and neurotrophic factors in neuronal plasticity and disease. Annals of the New York Academy of Sciences, 1144, 97-112.
38. Mayeux, R. (2003). Epidemiology of neurodegeneration. Annual Review of Neuroscience, 26, 81-104.
39. Ming, G., Henley, J., Tessier-lavigne, M., Song, H., & Poo, M. (2001). Electrical activity modulates growth cone guidance by diffusible factors. Neuron, 29, 441-452.
40. Ming, G. L., & Song, H. (2005). Adult neurogenesis in the mammalian central nervous system. Annual Review of Neuroscience, 28, 223-250.
41. Monfort, P., Munoz, M. D., Kosenko, E., & Felipo, V. (2002). Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cgmp-dependent protein kinase, and cgmp-degrading phosphodiesterase. Journal of Neuroscience, 22, 10116-10122.
42. Morano, S., Mandosi, E., Fallarino, M., Gatti, A., Tiberti, C., Sensi, M., et al. (2007). Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: A double-blind, placebo-controlled study. European Urology, 52, 1768-1774.
43. Patil, C. S., Singh, V. P., & Kulkarni, S. K. (2006). Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats. Pharmacological Reports, 58, 373-380.
44. Prast, H., Tran, M. H., Fischer, H., & Philippu, A. (1998). Nitric oxide-induced release of acetylcholine in the nucleus accumbens: Role of cyclic gmp, glutamate, and gaba. Journal of Neurochemistry, 71, 266-273.
45. Prickaerts, J., De Vente, J., Honig, W., Steinbusch, H. W., & Blokland, A. (2002a). Cgmp, but not camp, in rat hippocampus is involved in early stages of object memory consolidation. European Journal of Pharmacology, 436, 83-87.
46. Prickaerts, J., Van Staveren, W. C., Sik, A., Markerink-Van Ittersum, M., Niewohner, U., Van Der staay, F. J., et al. (2002b). Effects of two selective phosphodiesterase type 5 inhibitors, sildenafil and vardenafil, on object recognition memory and hippocampal cyclic gmp levels in the rat. Neuroscience, 113, 351-361.
47. Puzzo, D., Staniszewski, A., Deng, S. X., Privitera, L., Leznik, E., Liu, S., et al. (2009). Phosphodiesterase 5 inhibition improves synaptic function, memory, and amyloid-beta load in an alzheimer's disease mouse model. Journal of Neuroscience, 29, 8075-8086.
48. Rashid, A. (2005). The efficacy and safety of pde5 inhibitors. Clinical Cornerstone, 7, 47-56.
49. Rentzos, M., Michalopoulou, M., Nikolaou, C., Cambouri, C., Rombos, A., Dimitrakopoulos, A., et al. (2005). The role of soluble intercellular adhesion molecules in neurodegenerative disorders. Journal of Neurological Sciences, 228, 129-135.
50. Schulz, E., Tsilimingas, N., Rinze, R., Reiter, B., Wendt, M., Oelze, M., et al. (2002). Functional and biochemical analysis of endothelial (dys) function and no/cgmp signaling in human blood vessels with and without nitroglycerin pretreatment. Circulation, 105, 1170-1175.
51. Song, Y. S., Park, H. J., Kim, S. Y., Lee, S. H., Yoo, H. S., Lee, H. S., et al. (2004). Protective role of bcl-2 on beta-amyloid-induced cell death of differentiated pc12 cells: Reduction of nf-kappab and p38 map kinase activation. Neuroscience Research, 49, 69-80.
52. Spieker, L. E., Hurlimann, D., Ruschitzka, F., Corti, R., Enseleit, F., Shaw, S., et al. (2002). Mental stress induces prolonged en-dothelial dysfunction via endothelin - a receptors. Circulation, 105, 2817-2820.
53. Terry, A. V., Jr., & Buccafusco, J. J. (2003). The cholinergic hypothesis of age and alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development. The Journal of Pharmacology and Experimental Therapeutics, 306, 821-827.
54. Uthayathas, S., Karuppagounder, S. S., Thrash, B. M., Parameshwaran, K., Suppiramaniam, V., & Dhanasekaran, M. (2007). Versatile effects of sildenafil: Recent pharmacological applications. Pharmacological Reports, 59, 150-163.
55. Wang, R., Dineley, K. T., Sweatt, J. D., & Zheng, H. (2004). Presenilin 1 familial alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neuroscience, 126, 305-312.
56. Zhang, R., Wang, Y., Zhang, L., Zhang, Z., Tsang, W., Lu, M., et al. (2002). Sildenafil (viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke, 33, 2675-2680.